{"id":"W2487481595","doi":"10.1002/clc.22562","title":"Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the <scp>TRILOGY ACS</scp> Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"AstraZeneca Schweiz; GlaxoSmithKline; Janssen Pharmaceuticals; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Duke Clinical Research Institute; Daiichi Sankyo Europe; Sanofi; American Heart Association","keywords":"Medicine; Atrial fibrillation; Cardiology; Internal medicine; Revascularization; Clopidogrel; Aspirin; Intensive care medicine; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007515815,0.0002603481,0.001272822,0.0001038276,0.0001099372,0.00002421998,0.00009659737,0.0003893274,0.00001437782],"category_scores_gemma":[0.001815179,0.0001248311,0.000250935,0.0001550893,0.0005321702,0.0001452469,0.0001525623,0.0002180466,0.00001067049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002364984,"about_ca_system_score_gemma":0.00006090551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000931277,"about_ca_topic_score_gemma":0.000009138871,"domain_scores_codex":[0.9970967,0.0008623563,0.0008527203,0.0005824449,0.000348499,0.0002573128],"domain_scores_gemma":[0.9945143,0.004583707,0.0002751797,0.000395462,0.00009460712,0.0001367587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009293646,0.000006183691,0.9766144,0.000004704268,0.001399556,0.00005541979,0.0000546739,0.00000309705,0.000006219437,0.0001842273,0.0001651015,0.01221281],"study_design_scores_gemma":[0.09229335,0.001718126,0.8981906,0.00003239948,0.0004167951,0.00001612647,0.00002169814,0.00001120777,8.442128e-7,0.0004750114,0.006746165,0.00007774047],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933276,0.0005688908,0.0002503999,0.003202015,0.0008319691,0.00167121,0.00002065447,0.00005308297,0.00007419608],"genre_scores_gemma":[0.9942889,0.002581241,0.0001860912,0.0004729414,0.002091848,0.000003262257,0.0001371799,0.00002719547,0.0002113644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08299971,"threshold_uncertainty_score":0.5090463,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05330609231790877,"score_gpt":0.3313165372568068,"score_spread":0.278010444938898,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}